On Wednesday, Shares of Facebook, Inc. (NASDAQ:FB), gained 1.78% to $96.99.
Facebook stated financial results for the quarter ended June 30, 2015.
Second Quarter 2015 Operational Highlights
- Daily active users (DAUs) – DAUs were 968 million on average for June 2015, an enhance of 17% year-over-year.
- Mobile DAUs – Mobile DAUs were 844 million on average for June 2015, an enhance of 29% year-over-year.
- Monthly active users (MAUs) – MAUs were 1.49 billion as of June 30, 2015, an enhance of 13% year-over-year.
- Mobile MAUs – Mobile MAUs were 1.31 billion as of June 30, 2015, an enhance of 23% year-over-year.
Facebook, Inc. operates as a social networking company worldwide. It provides a set of development tools and application programming interfaces that enable developers to integrate with Facebook to create mobile and Web applications.
Shares of Immunomedics Inc. (NASDAQ:IMMU), declined -17.25% to $2.11, during its last trading session, after analysts at Jefferies downgraded the stock, citing its disappointing results of epratuzumab trials.
In a report published Wednesday, Jefferies analyst Chris Howerton downgraded the rating on Immunomedics, Inc. from Buy to Hold, while reducing the price target from $6 to $2, after the company’s partner stated disappointing results of epratuzumab trials, according to Benzinga.
In the report Jefferies noted, “…the strongest pipeline potential for IMMU lies in IMMU-132 for TNBC, where 2 complete responses (CR) has been observed and positive progression free survival (PFS) benefits of up to 6.0 months. At this time, mgmt is determining the registration path forward in talk aboutions with the FDA (likely in TNBC), and is actively seeking a partner preceding to initiating any phase 3 trials.” Benzinga Reports
Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States.
Finally, United Parcel Service, Inc. (NYSE:UPS), ended its last trade with 0.95% gain, and closed at $100.89.
United Parcel Service declared agreements for up to 46 million gallons of renewable fuels over the next three years, constituting a 15-fold enhance over preceding contracts and making UPS one of the largest users of renewable diesel in the world.
The agreements with three leading suppliers of renewable fuels, secure access to an advanced renewable diesel fuel in order to meet the company’s objectives for alternative fuel utilization. Neste, Renewable Energy Group (REG) and Solazyme will supply renewable diesel to UPS to assist facilitate the company’s shift to move more than 12% of its purchased ground fuel from conventional diesel and gasoline fuel to alternative fuels by the end of 2017. UPS has formerly declared a aim of driving one billion miles with our alternative fuel and advanced technology vehicles by the end of 2017.
“Advanced alternative fuels like renewable diesel are an important part of our strategy to reduce the carbon emissions impact of our fleet,” said Mark Wallace, UPS senior vice president, global engineering and sustainability. “We have used more than three million gallons of renewable diesel to date with positive results. Renewable diesel has a huge impact significantly reducing lifecycle greenhouse gas emissions by up to 90 percent less as compared to conventional petroleum diesel. Renewable diesel also performs well in cold weather, does not have any blending limitations and can be easily ‘dropped in’ to our fuel supply chain without modifications to our existing diesel trucks and equipment.”
United Parcel Service, Inc., a package delivery company, provides transportation, logistics, and financial services in the United States and internationally. It operates in three segments: U.S. Domestic Package, International Package, and Supply Chain & Freight.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
